Applied Genetic Tech (AGTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2012 | 06-2007 | 06-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -1,924 | N/A | N/A |
| Depreciation Amortization | 262 | N/A | N/A |
| Accounts payable and accrued liabilities | -24 | N/A | N/A |
| Other Working Capital | 447 | N/A | N/A |
| Other Operating Activity | -133 | 0 | 0 |
| Operating Cash Flow | $-1,372 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -108 | N/A | N/A |
| Investing Cash Flow | $-108 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Debt Issued | 750 | N/A | N/A |
| Debt Repayment | -323 | N/A | N/A |
| Financing Cash Flow | $427 | $N/A | $N/A |
| Beginning Cash Position | 1,827 | N/A | N/A |
| End Cash Position | 774 | N/A | N/A |
| Net Cash Flow | $-1,053 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -1,372 | N/A | N/A |
| Capital Expenditure | -108 | N/A | N/A |
| Free Cash Flow | -1,480 | 0 | 0 |